Soligenix, Inc. (SNGX) announced the results of its 2026 annual meeting of stockholders, held on September 17, 2026. During the meeting, stockholders approved several amendments to the company's governing documents, including an increase in authorized shares and the authorization of a reverse stock split.
The primary action taken was the approval of a Charter Amendment to the Second Amended and Restated Certificate of Incorporation. This amendment increased the number of authorized shares of common stock from 75,000,000 to 125,000,000. The amendment became effective upon filing with the Secretary of State of Delaware on September 17, 2026.
Separately, stockholders approved a proposal to amend the company's certificate of incorporation to allow for a reverse stock split. The Board of Directors is authorized to execute this split at its discretion for a period of up to one year. The split ratio is to be determined by the Board and will range from 1-for-2 to 1-for-20.
In addition to the capital structure changes, the following matters were voted on:
- Director Election: Five nominees were elected to the board. Christopher J. Schaber, PhD, Gregg A. Lapointe, Diane L. Parks, Robert J. Rubin, and Jerome B. Zeldis, MD, PhD, were all elected to serve until the 2027 annual meeting.
- Auditor Ratification: Stockholders ratified the appointment of Cherry Bekaert LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026.
- Executive Compensation: A non-binding advisory vote approved the compensation of the company's named executive officers. Stockholders also voted to hold future advisory votes on executive compensation annually.
On June 26, 2026, the company filed a prospectus supplement to its At Market Issuance Sales Agreement with Rodman & Renshaw LLC. This supplement increased the maximum aggregate offering amount of common stock by an additional $2,500,000. The company had previously sold approximately $6,234,000 of shares under the agreement.
